|
1
|
Global status report on alcohol and
health. World Health Organization; Geneva, Switzerland: 2011
|
|
2
|
Lu XL, Tao M, Luo JY, Geng Y, Zhao HL and
Zhao P: Epidemiology of alcohol and liver disease. Zhonghua Gan
Zang Bing Za Zhi. 6:467–468. 2002.(In Chinese).
|
|
3
|
Park SH, Kim CH, Kim DJ, et al: Prevalence
of alcoholic liver disease among Korean adults: Results from the
Fourth Korea National Health and Nutrition Examination Survey,
2009. Subst Use Misuse. 46:1755–1762. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim KA: Current status of liver diseases
in Korea: toxic and alcoholic liver diseases. Korean J Hepatol.
15:(Sul 6). S29–S33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takada A and Tsutsumi M: National survey
of alcoholic liver disease in Japan (1968–91). J Gastroenterol
Hepatol. 10:509–516. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Horie Y, Ishii H and Hibi T: National
survey of alcoholic liver disease in Japan. Nihon Arukoru Yakubutsu
Igakkai Zasshi. 39:505–510. 2004.(In Japanese). PubMed/NCBI
|
|
7
|
Lucey MR, Mathurin P and Morgan TR:
Alcoholic hepatitis. N Engl J Med. 360:2758–2769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pirmohamed M, Brown C, Owens L, Luke C,
Gilmore IT, Breckenridge AM and Park BK: The burden of alcohol
misuse on an inner-city general hospital. QJM. 93:291–295. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pirmohamed M and Gilmore IT: Alcohol abuse
and the burden on the NHS - time for action. J R Coll Physicians
Lond. 34:161–162. 2000.PubMed/NCBI
|
|
10
|
Madhotra R and Gilmore IT: Recent
developments in the treatment of alcoholic hepatitis. QJM.
96:391–400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barve A, Khan R, Marsano L, Ravindra KV
and McClain C: Treatment of alcoholic liver disease. Ann Hepatol.
7:5–15. 2008.PubMed/NCBI
|
|
12
|
Huxtable RJ: Physiological actions of
taurine. Physiol Rev. 72:101–163. 1992.PubMed/NCBI
|
|
13
|
Chen X, Sebastian BM, Tang H, McMullen MM,
Axhemi A, Jacobsen DW and Nagy LE: Taurine supplementation prevents
ethanol-induced decrease in serum adiponectin and reduces hepatic
steatosis in rats. Hepatology. 49:1554–1562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kerai MD, Waterfield CJ, Kenyon SH, Asker
DS and Timbrell JA: Taurine: Protective properties against
ethanol-induced hepatic steatosis and lipid peroxidation during
chronic ethanol consumption in rats. Amino Acids. 15:53–76. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu G, Yang J, Sun C, Luan X, Shi J and Hu
J: Effect of taurine on alcoholic liver disease in rats. Amino
Acids. 36:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang YY, Chou CH, Chiu CH, Yang KT, Lin
YL, Weng WL and Chen YC: Preventive effects of taurine on
development of hepatic steatosis induced by a high fat/cholesterol
dietary habit. J Agric Food Chem. 59:450–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harada S, Misawa S, Agarwal DP and Goedde
HW: Liver alcohol dehydrogenase and aldehyde dehydrogenase in the
Japanese: Isozyme variation and its possible role in alcohol
intoxication. Am J Hum Genet. 32:8–15. 1980.PubMed/NCBI
|
|
18
|
Goedde HW, Agarwal DP, Harada S,
Meier-Tackmann D, Ruofu D, Bienzle U, Kroeger A and Hussein L:
Population genetic studies on aldehyde dehydrogenase isozyme
deficiency and alcohol sensitivity. Am J Hum Genet. 35:769–772.
1983.PubMed/NCBI
|
|
19
|
Matsuda Y, Tsuchishima M, Ueshima Y,
Takase S and Takada A: The relationship between the development of
alcoholic liver and pancreatic diseases and the induction of gamma
glutamyl transferase. Alcohol Alcohol Suppl. 1B:27–33.
1993.PubMed/NCBI
|
|
20
|
Conigrave KM, Davies P, Haber P and
Whitfield JB: Traditional markers of excessive alcohol use.
Addiction. 98:(Suppl 2). 31–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuka Y, Wang D-H, Suganuma N, Imai K,
Ikeda S, Taketa K and Kira S: Differential responses of serum
gamma-glutamyltransferase to alcohol intake in Japanese males. Acta
Med Okayama. 57:171–178. 2003.PubMed/NCBI
|
|
22
|
Bell H and Steensland H: Serum activity of
gamma-glutamyltranspeptidase (GGT) in relation to estimated alcohol
consumption and questionnaires in alcohol dependence syndrome. Br J
Addict. 82:1021–1026. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steffensen FH, Sørensen HT, Brock A,
Vilstrup H and Lauritzen T: Alcohol consumption and serum
liver-derived enzymes in a Danish population aged 30–50 years. Int
J Epidemiol. 26:92–99. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anton RF, Lieber C and Tabakoff B: CDTect
Study Group: Carbohydrate-deficient transferrin and
gamma-glutamyltransferase for the detection and monitoring of
alcohol use: Results from a multisite study. Alcohol Clin Exp Res.
26:1215–1222. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lakshman MR: Some novel insights into the
pathogenesis of alcoholic steatosis. Alcohol. 34:45–48. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang C, Li X, Jing X, Zhang B, Zhang Q,
Niu Q, Wang J and Tian Z: Protective effects of oyster extract
against hepatic tissue injury in alcoholic liver diseases. J Ocean
Univ China. 13:262–270. 2014. View Article : Google Scholar
|
|
27
|
Fujisawa H, Takehara I, Nishihori Y, Yano
Y, Yamazaki N, Matsui H, Matsuda Y and Fukuhara I: Effect of 12
weeks ingestion of oyster extract on hepatic function in human
volunteers with mild alcoholic liver damage. Trace Nutr Res.
29:13–17. 2012.(In Japanese).
|
|
28
|
Matsuda Y, Izuta S, Fujita T, Ohta T,
Nakatsuka M, Yoshino M and Shibata Y: Influence of oyster extract
administration of diabetes mellitus and hepatitis patients. Trace
Nutr Res. 12:91–97. 1995.(In Japanese).
|
|
29
|
Ming Z, Shimizu Y, Furuta K, Tanaka S and
Gohda E: Acceleration of alcohol metabolism by Crassostera gigas
extract. Jpn Pharmacol Ther. 41:319–321. 2013.(In Japanese).
|
|
30
|
Devi SL, Viswanathan P and Anuradha CV:
Regression of liver fibrosis by taurine in rats fed alcohol:
Effects on collagen accumulation, selected cytokines and stellate
cell activation. Eur J Pharmacol. 647:161–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang L, Latchoumycandane C, McMullen MR,
Pratt BT, Zhang R, Papouchado BG, Nagy LE, Feldstein AE and
McIntyre TM: Chronic alcohol exposure increases circulating
bioactive oxidized phospholipids. J Biol Chem. 285:22211–22220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Latchoumycandane C, Nagy LE and McIntyre
TM: Chronic ethanol ingestion induces oxidative kidney injury
through taurine-inhibitable inflammation. Free Radic Biol Med.
69:403–416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tanaka K, Nishizono S, Kugino K, Tamari M,
Kurumiya M, Abe N and Ikeda I: Effects of dietary oyster extract on
lipid metabolism, blood pressure and blood glucose in SD rats,
hypertensive rats and diabetic rats. Biosci Biotechnol Biochem.
70:462–470. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshikawa T, Naito Y, Masui K, Fujii T,
Boku Y, Nakagawa S, Yoshida N and Kondo M: Free radical-scavenging
activity of Crassostera gigas extract (JCOE). Biomed Pharmacother.
51:328–332. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nishihori Y, Suzuki Y, Kishinami M,
Fujisawa H, Nagaoka S, Yamazaki N, Matsui H and Matsuda Y: Study of
safety and functionality in oyster extract powder. Trace Nutr Res.
28:40–44. 2011.
|
|
36
|
Wójcik OP, Koenig KL, Zeleniuch-Jacquotte
A, Costa M and Chen Y: The potential protective effects of taurine
on coronary heart disease. Atherosclerosis. 208:19–25. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chesney RW: Taurine: Its biological role
and clinical implications. Adv Pediatr. 32:1–42. 1985.PubMed/NCBI
|
